zepbound tirzepatide eli lilly launches lower-price weight-loss drug without injector pen Lilly releases Zepbound® (tirzepatide) single-dose

The FDA initially allowed the compounding of certain GLP-1 and GIP medications, like Tirzepatide, because these drugs were in a national shortage

Clinical trials have shown that people using Tirzepatide for weight loss have seen significant reductions in body weight between 15% and 22.5% on average over 72 weeks

If you are on semaglutide 1.7 mg or 2.4 mg, some practitioners start tirzepatide at 5 mg rather than 2.5 mg, reasoning that the GLP-1 tolerance you have built will carry over partially

It also ranks among the most popular peptides 2026 by real-world demand

For most people, headaches are temporary and manageable

Severe GI adverse reactions were reported in 4.1% and 0.9% of Wegovy -injection treated and placebo treated patients, respectively, and in 2% of Wegovy tablet-treated and 0% of placebo treated patients, respectively